Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The effect of vilazodone, a putative selective serotonin re-uptake inhibitor (SSRI) with 5-HT (5-hydroxytryptamine)(1A) receptor partial agonist activity, was investigated on 5-HT efflux and 5-HT re-uptake half life in the guinea-pig dorsal raphe nucleus, using in vitro fast cyclic voltammetry. The SSRI, fluoxetine, significantly increased 5-HT efflux. In contrast, vilazodone had no effect on 5-HT efflux at 100 nM but significantly decreased 5-HT efflux at 1 microM. Co-perfusion of 8-OH-DPAT (+/-8-hydroxy-2-(di-n-propylamino)tetralin) with fluoxetine significantly attenuated the fluoxetine-induced increase in 5-HT efflux. Co-perfusion of WAY 100635 with vilazodone did not attenuate the effect of vilazodone alone. In addition, the re-uptake half life for 5-HT was significantly increased by both fluoxetine and vilazodone. In conclusion, we have demonstrated that vilazodone (100 nM, 1 microM), in the guinea-pig dorsal raphe nucleus, blocks the serotonin transporter but does not display 5-HT(1A) receptor agonism.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejphar.2005.05.039 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cell membrane cholesterol affects serotonin transporter efflux due to altered transporter oligomerization.
Mol Psychiatry
September 2025
Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria.
The human monoamine transporters (MATs) for serotonin (SERT), dopamine (DAT), and norepinephrine (NET) play a key role in neurotransmission by transporting neurotransmitters from the synaptic cleft back into the neuron. MATs are embedded in the cell membrane's lipid bilayer, encompassing cholesterol, phospholipids, and sphingolipids as main components. Membrane cholesterol association has been shown for all MATs impacting transporter conformation, substrate affinity, transport velocity, and turnover rates.
View Article and Find Full Text PDFPharmacological Evaluation of Tropane Analogues at the Serotonin Transporter.
ACS Chem Neurosci
September 2025
Institute for Psychedelics and Neurotherapeutics, University of California Davis, Davis, California 95616, United States.
Tropane alkaloids and their derivatives represent a diverse class of small molecules with a broad range of therapeutic applications. Many tropanes regulate synaptic levels of neuromodulators by interacting with monoamine transporters such as dopamine (DAT) and serotonin (SERT) transporters. While DAT inhibition plays an important role in the addictive potential of tropanes such as cocaine, recent evidence suggests that SERT modulation may oppose the effects of DAT inhibition.
View Article and Find Full Text PDFSetup and Evaluation of the TRACT Assay Principle for the Functional Characterization of Modulators of the Serotonin Transporter and the Serotonin 2A Receptor.
Anal Chem
August 2025
Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.
The human serotonin transporter (SERT) is a pertinent target for many psychiatric therapeutics and recreational drugs including new psychoactive substances. Current techniques to assess SERT inhibition typically monitor the uptake of radiolabeled or fluorescent substrates but face limitations regarding the use of nonendogenous substrates and/or low throughput. Inspired by a previously reported principle, coined 'TRACT' or 'transporter activity through receptor activation', a new bioassay to measure SERT inhibition was developed.
View Article and Find Full Text PDFProtective Effect of Palonosetron against Cisplatin-Induced Cytotoxicity via Decreased Phosphorylation of p38.
Biol Pharm Bull
July 2025
Department of Pharmacy, The University of Osaka Hospital, 2-15 Yamadaoka, Suita, Osaka 565-0871, Japan.
The dose-limiting nephrotoxicity of cisplatin (CDDP) is attributed to its accumulation in renal epithelial cells, mediated by uptake via human organic cation transporter 2 (hOCT2) and efflux via human multidrug and toxin extrusion 1 (hMATE1), followed by apoptosis induction via p38 phosphorylation. Recently, we demonstrated that the incidence of CDDP-induced nephrotoxicity was significantly lower in patients receiving palonosetron, a 5-hydroxytryptamine 3 receptor antagonist (5-HTRA), than in those receiving other 5-HTRAs (ondansetron, ramosetron, and granisetron). However, the underlying mechanism through which palonosetron induces a renoprotective effect remains unclear.
View Article and Find Full Text PDFResearch progress on the synergistic effect and its mechanisms of antidepressants and antibiotics against resistant pathogens.
Arch Microbiol
May 2025
Department of Clinical Laboratory, Gansu Provincial Hospital, Lanzhou, 730000, China.
Antimicrobial resistance (AMR) poses a critical global health challenge, driving the urgent need for innovative therapeutic strategies. Antidepressants, traditionally used for major depressive disorders (MDD), have recently attracted attention in non-antibiotic research due to their diverse pharmacological properties, including antimicrobial, antifungal, antiviral, anticancer, antiparasitic, and anti-inflammatory activities. Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) demonstrated synergistic antimicrobial effects with reduced minimum inhibitory concentrations (MIC) when used in combination with conventional antibiotics, enhancing efficacy against drug-resistant pathogens.
View Article and Find Full Text PDF